Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Evaxion Biotech A/S (EVAX)

2.91   0.48 (19.75%) 09-24 16:32
Open: 2.4 Pre. Close: 2.43
High: 3.0682 Low: 2.2917
Volume: 1,093,718 Market Cap: 70(M)
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.07 - 3.09 3.09 - 3.1
Low: 2.27 - 2.28 2.28 - 2.29
Close: 2.89 - 2.91 2.91 - 2.93

Technical analysis

as of: 2022-09-23 4:23:54 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 4.11     One year: 4.8
Support: Support1: 2.51    Support2: 1.89
Resistance: Resistance1: 3.51    Resistance2: 4.11
Pivot: 2.15
Moving Average: MA(5): 2.3     MA(20): 2.2
MA(100): 2.24     MA(250): 3.56
MACD: MACD(12,26): -0.1     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 40.5     %D(3): 23.4
RSI: RSI(14): 68.6
52-week: High: 25.04  Low: 1.5
Average Vol(K): 3-Month: 827 (K)  10-Days: 4,787 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ EVAX ] has closed Bollinger Bands are 26.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 23 Sep 2022
Healthcare Stocks Moving Up and Down Friday: ATHX, CO, XRTX, EVAX, ATXI, AORT, CWBR, CASI - InvestorsObserver

Thu, 22 Sep 2022
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace

Thu, 22 Sep 2022
It is Poised to be a Bull Market for Evaxion Biotech A/S (EVAX) - SETE News

Thu, 22 Sep 2022
Good Penny Stocks to Add to Your Buy List? 3 to Watch -

Wed, 21 Sep 2022
Health Care Sector Update for 09/21/2022: EVAX,VTRS,OMCL,SHC - Nasdaq

Wed, 21 Sep 2022
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.70% By - UK

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 24 (M)
Shares Float 14 (M)
% Held by Insiders 42.8 (%)
% Held by Institutions 0.9 (%)
Shares Short 195 (K)
Shares Short P.Month 203 (K)

Stock Financials

EPS -1.26
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.85
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -53.3
Return on Equity (ttm) -115.2
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.1
Qtrly Earnings Growth 0
Operating Cash Flow -24 (M)
Levered Free Cash Flow -15 (M)

Stock Valuations

PE Ratio -2.32
PEG Ratio 0
Price to Book value 3.42
Price to Sales 0
Price to Cash Flow -2.92

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.